Lupron is Not a Suicide Prophylaxis
Lupron is Not a Suicide Prophylaxis
10 reality based facts about puberty blockers to challenge the narrative
Acronym Glossary
HPG Axis — Hypothalamic-Pituitary-Gonadal Axis (sex and reproduction)
HPA Axis — Hypothalamic-Pituitary-Adrenal Axis (stress response)
GnRH — Gonadotropin-Releasing Hormone (signals Pituitary)
GnRHa — Gondatropin-Releasing Hormone Analogue (a synthetic version of GnRH)
PuBl — Puberty Blockers, the woke euphemism for GnRHa (GnRHa is 4 times more potent than endogenous GnRH)
PPE — Personal Protective Equipment (double gloving for administering Lupron)
10 facts about puberty blockers progressives are hiding from you
The following 10 facts have solid valid + reliable evidence to support them. I have a ongoing reference list in Zotero and I add citations daily as I research and conduct literature searches. Whenever possible I try to include the relevant studies here in my Substack articles. References are now tacked onto the end.
Consider becoming a paid subscriber to help this publication research and write posts like this to expose the truth about Puberty Blockers aka Lupron and to debunk Gender Affirming Care.
Puberty Blocker (PuBl) is on the Hazardous Drugs List
Leuprolide Acetate is listed on the NIOSH Hazardous Drugs List. In Canada, it is listed on the provincial Hazardous Drug or Anti-Neoplastic Drugs lists. Occupational exposure requires PPE commensurate with any other parenteral cancer chemotherapy drug. The video which BC Children’s Hospital provides to instruct parents on administering Lupron to their kids does not include a warning about Universal Precautions required. The BCCH website which promotes Lupron for Pediatric Gender Dysphoria does not provide any Universal Precaution or Hazardous Drug warning. In fact the manufacturer’s video instructs the viewer to pull back the syringe and expel air — an obvious NO-NO with a Hazardous Drug. Are pregnant or conceiving mothers of Lupron Gender Dysphoria kids warned about the danger to them or their fetus? GnRHa is a teratogen.
PuBl has a 3 decades long history of significant + severe iatrogenic harm
Mounds of evidence, painstakingly collected for over 2 decades by former Emergency Room Nurse and Paralegal Lynne Millican. Lupron Victim Hub contains a wealth of damning information about Lupron’s debilitating effect on thousand and thousand of people, mainly women, who took it unsuspectingly when their doctor’s prescribed it unsuspectingly. TAP Pharmaceutical has a known history of exaggerating benefits and understating harmful effects of GnRHa, including falsifying clinical data supporting the use of Lupron for endometrial pain.
PuBl was intended to be a compassionate option to surgical castration
of the testicles in men with end stage metastatic prostate cancer — truly this made the synthesis of GnRH analogue so revolutionary! No more surgical removal of testicles to induce hypoandrogenism! Can you imagine the significance? How twisted that now we live in a time where GnRHa means the child patient will most certainly undergo surgical excision of the gonads? A drug created to save the gonads is being used to destroy them. Deliberately. As part of an experiment. To affirm an adolescent feeling.
No valid + reliable evidence exists to prove that PuBl saves kids’ lives
However much valid + reliable evidence exists to suggest that PuBl pose an iatrogenic danger to children. Over a quarter century of caseload evidence exist to prove that GnRH agonist is a poison to the human body and must be restricted severely. The deluge of useless studies that Gender Affirmation-biased researchers and clinicians publish, and the “trans kid” agenda which the compliant media continues to promote without critically questioning it, has caused pediatric medicine and counseling therapy also, to falter + fail society.
PuBl does not affirm a child, it lobotomises the hypothalamus and pituitary
The Hypothalamus is the smart centre and the Pituitary is the master gland of the brain. These two parts of the brain regulate and manage many other functions in the brain and nervous system and body. GnRH analogue lobotomises, ie neurally isolates + stuns + shrinks, these brain centres. To use a physical example: when you stunt the power centre and electric circuitry of your computer and interrupt its major OS upgrade, you could brick your computer, or otherwise render it unusable.
PuBl shuts down a major neuromodulation mechanism — the HPG Axis
PuBl are used to suppress sex drive in pedophiles because GnRH analogue is the chemical version of castration, de-sexing. The Hypothalamic-Pituitary-Gonadal Axis is the neuro-endocrine mechanism through which the gonads and the brain communicate. GnRH analogue severs the connection between the H+P and the G of the HPG. Sex isn’t just for procreation, it is for a bunch of other important metabolic and immune and thinking functions. When you chemically alter a child’s brain in this way before it has had a chance to fully grow, what are you doing? Probably not affirming them. Dis-homeostasis of the HPG Axis is a driver of neurodegeneration.
PuBl interrupts the neuromodulating effect of the Gonads on the adrenal system
PuBl interrupts the capacity of the sex organs to down-regulate immune and stress (flight or fight) responses. Estrogen enhances and Testosterone inhibits HPA function. Crudely meaning E intensifies and T stunts emotional reactivity. PuBl create an unnatural hormonal balance in the body by suppressing all gonadotropins. A 2014 case presentation of 3 young children with precocious puberty treated with PuBl (access a copy at the end of this list) concluded that, any factor that inhibits the action of estrogen or decreases its serum levels (such as seen with GnRHa) can potentially trigger mood instability or even psychotic symptoms because estrogen regulates dopamine DR-2 and 5H2Ta, and these two neurochemicals play a role in signalling the HPA Axis to respond to stress in a fight/flight/freeze as well as immune response.
PuBl impairs glucose metabolism and promotes insulin resistance
Estrogen receptors in the brain regulate body weight, energy expenditure and fat distribution. Multiple studies demonstrate an association between dysfunction of the reproductive neuroendocrine axis and insulin resistance, ie hyperinsulinema. Insulin plays a role in reproduction at the hypothalamic level. In fact, insulin research has begun to implicate insulin in the regulation of hypothalamic GnRH pulsatile activity.
Individuals with a damaged HPA Axis mimic a dysphoria symptom profile
Attachment disorders, childhood maltreatment, and Adverse Childhood Events (ACEs) damage the HPA Axis and produce altered and chronic stress responses. Children with neurodevelopmental disorders such as autism will have an atypical HPA Axis. These kids will present to clinicians + counsellors with the same symptom profile as sex/body/gender dysphoria. Differential diagnosis is key to screening theses kids out of the Gender Affirming Care pathway.
PuBl is not licensed to “affirm gender” in children
GnRHa makers have a consistent and lengthy history of exaggerating benefits and understating adverse reactions throughout the lifetime of their product. They continue to fudge the data, to manipulate comparatives to distort results. In fact TAP Holdings confessed to falsification of clinical data — Andrew Friedman made up the data to support treatment of endometrial disease. AbbVie knows well no evidence exists to support the use of GnRHa to affirm pediatric gender, it chooses to say nothing and in fact pays organisations and clinicians who promote Lupron as a remedy for gender confusion in kids.
References
Acevedo‐Rodriguez, A., Kauffman, A. S., Cherrington, B. D., Borges, C. S., Roepke, T. A., & Laconi, M. (2018). Emerging insights into hypothalamic‐pituitary‐gonadal axis regulation and interaction with stress signalling. Journal of Neuroendocrinology, 30(10). https://doi.org/10.1111/jne.12590
Adams, G. C., Wrath, A. J., Von Dewitz, B., Marciniuk, K., Roesler, A., & Napper, S. (2020). Attachment impacts cortisol awakening response in chronically depressed individuals. Psychoneuroendocrinology, 120, 104778. https://doi.org/10.1016/j.psyneuen.2020.104778
Bangalore Krishna, K., Fuqua, J. S., Rogol, A. D., Klein, K. O., Popovic, J., Houk, C. P., Charmandari, E., & Lee, P. A. (2019). Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium. Hormone Research in Paediatrics, 91(6), 357–372. https://doi.org/10.1159/000501336
Chen, T., Yu, W., Xie, X., Ge, H., Fu, Y., Yang, D., Zhou, L., Liu, X., & Yan, Z. (2020). Influence of Gonadotropin Hormone Releasing Hormone Agonists on Interhemispheric Functional Connectivity in Girls With Idiopathic Central Precocious Puberty. Frontiers in Neurology, 11, 17. https://doi.org/10.3389/fneur.2020.00017
Craig, M. C., Fletcher, P. C., Daly, E. M., Rymer, J., Cutter, W. J., Brammer, M., Giampietro, V., Wickham, H., Maki, P. M., & Murphy, D. G. M. (2007a). Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology, 32(8–10), 1116–1127. https://doi.org/10.1016/j.psyneuen.2007.09.009
Craig, M. C., Fletcher, P. C., Daly, E. M., Rymer, J., Cutter, W. J., Brammer, M., Giampietro, V., Wickham, H., Maki, P. M., & Murphy, D. G. M. (2007b). Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology, 32(8–10), 1116–1127. https://doi.org/10.1016/j.psyneuen.2007.09.009
DiVall, S. A., Herrera, D., Sklar, B., Wu, S., Wondisford, F., Radovick, S., & Wolfe, A. (2015). Insulin Receptor Signaling in the GnRH Neuron Plays a Role in the Abnormal GnRH Pulsatility of Obese Female Mice. PLOS ONE, 10(3), e0119995. https://doi.org/10.1371/journal.pone.0119995
Friedman, A. J., Juneau-Norcross, M., & Rein, M. S. (1993). Adverse effects of leuprolide acetate depot treatment. Fertility and Sterility, 59(2), 448–450. https://doi.org/10.1016/S0015-0282(16)55701-X
Gooren, L., & Delemarre-van De Waal, H. (1996). The Feasibility of Endocrine Interventions in Juvenile Transsexuals. Journal of Psychology & Human Sexuality, 8(4), 69–74. https://doi.org/10.1300/J056v08n04_05
Handa, R. J., Burgess, L. H., Kerr, J. E., & O’Keefe, J. A. (1994). Gonadal Steroid Hormone Receptors and Sex Differences in the Hypothalamo-Pituitary-Adrenal Axis. Hormones and Behavior, 28(4), 464–476. https://doi.org/10.1006/hbeh.1994.1044
Hormones are key in brain health differences between men and women. (2021, February 1). American Heart Association News. https://www.heart.org/en/news/2021/02/01/hormones-are-key-in-brain-health-differences-between-men-and-women
Influence of Gonadotropin Hormone Releasing Hormone Agonists on Interhemispheric Functional Connectivity in Girls With Idiopathic Central Precocious Puberty. (2020). Front. Neurol, 11(17). https://doi.org/10.3389/fneur.2020.00017
Kuo, C.-Y., Chen, H.-C., & Lee, M.-B. (2014). Leuprolide-Induced Extrapyramidal Symptoms Successfully Treated With Propranolol. Psychosomatics, 55(2), 196–199. https://doi.org/10.1016/j.psym.2013.05.006
Lai, M. M., & Stohlman, S. A. (1978). RNA of mouse hepatitis virus. Journal of Virology, 26(2), 236–242. https://doi.org/10.1128/JVI.26.2.236-242.1978
LUPRON: MEMORY LOSS AND COGNITIVE. (1996). Lupron Victim Hub. https://www.lupronvictimshub.com/NLVN/NLVNfactsheetMemory.RTF
Melka, N., Pszczolinska, A., Klejbor, I., Ludkiewicz, B., Kowiański, P., & Moryś, J. (2021). Can the kisspeptin help us in the understanding of pathology of some neurodegenerative brain diseases? Folia Morphologica, 80(4), 756–765. https://doi.org/10.5603/FM.a2021.0090
Mosconi, L., Berti, V., Guyara-Quinn, C., McHugh, P., Petrongolo, G., Osorio, R. S., Connaughty, C., Pupi, A., Vallabhajosula, S., Isaacson, R. S., De Leon, M. J., Swerdlow, R. H., & Brinton, R. D. (2017). Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery. PLOS ONE, 12(10), e0185926. https://doi.org/10.1371/journal.pone.0185926
Mosconi, L., Rahman, A., Diaz, I., Wu, X., Scheyer, O., Hristov, H. W., Vallabhajosula, S., Isaacson, R. S., De Leon, M. J., & Brinton, R. D. (2018). Increased Alzheimer’s risk during the menopause transition: A 3-year longitudinal brain imaging study. PLOS ONE, 13(12), e0207885. https://doi.org/10.1371/journal.pone.0207885
Newton, C., Slota, D., Yuzpe, A. A., & Tummon, I. S. (1996). Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study. Fertility and Sterility, 65(6), 1253–1255. https://doi.org/10.1016/S0015-0282(16)58351-4
Rich, S. S., & Ovsiew, F. (1994). Leuprolide acetate for exhibitionism in huntington’s disease. Movement Disorders, 9(3), 353–357. https://doi.org/10.1002/mds.870090317
Robin, M., Schupak, T., Bonnardel, L., Polge, C., Couture, M.-B., Bellone, L., Shadili, G., Essadek, A., & Corcos, M. (2023). Clinical Stakes of Sexual Abuse in Adolescent Psychiatry. International Journal of Environmental Research and Public Health, 20(2), 1071. https://doi.org/10.3390/ijerph20021071
Rubinow, D. R., & Schmidt, P. J. (2019). Sex differences and the neurobiology of affective disorders. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 44(1), 111–128. https://doi.org/10.1038/s41386-018-0148-z
Sisk, C. L., & Foster, D. L. (2004). The neural basis of puberty and adolescence. Nature Neuroscience, 7(10), 1040–1047. https://doi.org/10.1038/nn1326
Skrapits, K., Sárvári, M., Farkas, I., Göcz, B., Takács, S., Rumpler, É., Váczi, V., Vastagh, C., Rácz, G., Matolcsy, A., Solymosi, N., Póliska, S., Tóth, B., Erdélyi, F., Szabó, G., Culler, M. D., Allet, C., Cotellessa, L., Prévot, V., … Hrabovszky, E. (2021). The cryptic gonadotropin-releasing hormone neuronal system of human basal ganglia. ELife, 10, e67714. https://doi.org/10.7554/eLife.67714
Sliwowska, J. H., Fergani, C., Gawałek, M., Skowronska, B., Fichna, P., & Lehman, M. N. (2014). Insulin: Its role in the central control of reproduction. Physiology & Behavior, 133, 197–206. https://doi.org/10.1016/j.physbeh.2014.05.021
Varney, N. R., Syrop, C., Kubu, C. S., Struchen, M., Hahn, S., & Franzen, K. (1993). Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. Journal of Assisted Reproduction and Genetics, 10(1), 53–57. https://doi.org/10.1007/BF01204441
Wickramasuriya, N., Hawkins, R., Atwood, C., & Butler, T. (2022). The roles of GnRH in the human central nervous system. Hormones and Behavior, 145, 105230. https://doi.org/10.1016/j.yhbeh.2022.105230
Xu, Y., Nedungadi, T. P., Zhu, L., Sobhani, N., Irani, B. G., Davis, K. E., Zhang, X., Zou, F., Gent, L. M., Hahner, L. D., Khan, S. A., Elias, C. F., Elmquist, J. K., & Clegg, D. J. (2011). Distinct Hypothalamic Neurons Mediate Estrogenic Effects on Energy Homeostasis and Reproduction. Cell Metabolism, 14(4), 453–465. https://doi.org/10.1016/j.cmet.2011.08.009
Yildirim, M., Mapp, O. M., Janssen, W. G. M., Yin, W., Morrison, J. H., & Gore, A. C. (2008). Postpubertal decrease in hippocampal dendritic spines of female rats. Experimental Neurology, 210(2), 339–348. https://doi.org/10.1016/j.expneurol.2007.11.003